Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Type I interferons play a key role in the development of various skin diseases.

Scoring systems help doctors assess and treat skin diseases effectively.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Apremilast shows promise for several skin conditions but needs more research.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Skin issues might be linked to infertility.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

The document lists various dermatology topics, treatments, and diagnostic methods.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The document is a detailed medical reference on skin and genetic disorders.

New treatments and understanding of skin lupus are emerging in 2024.

Targeted cancer therapies often cause serious skin problems that need careful management.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.